Supernus Pharmaceuticals, Inc. financial data

Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
Location
9715 Key West Avenue, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 188 % +48.1%
Quick Ratio 23.6 % +29.8%
Debt-to-equity 37.4 % -44.5%
Return On Equity 2.82 % -37.4%
Return On Assets 1.69 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.2M shares +1.07%
Common Stock, Shares, Outstanding 55.2M shares +1.78%
Entity Public Float 1.55B USD -5.44%
Common Stock, Value, Issued 55K USD 0%
Weighted Average Number of Shares Outstanding, Basic 55.1M shares +0.99%
Weighted Average Number of Shares Outstanding, Diluted 56M shares +2.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 176M USD +14.2%
Research and Development Expense 29M USD +28.2%
Costs and Expenses 135M USD -7.48%
Operating Income (Loss) 40.8M USD +402%
Nonoperating Income (Expense) 4.1M USD +134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 44.9M USD +354%
Income Tax Expense (Benefit) 6.45M USD -75.1%
Net Income (Loss) Attributable to Parent 38.5M USD
Earnings Per Share, Basic 0.7 USD/shares
Earnings Per Share, Diluted 0.69 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.7M USD -66.7%
Marketable Securities, Current 368M USD +170%
Accounts Receivable, after Allowance for Credit Loss, Current 145M USD +2.57%
Inventory, Net 64M USD -23.4%
Assets, Current 640M USD +42.4%
Property, Plant and Equipment, Net 11.9M USD -13.2%
Operating Lease, Right-of-Use Asset 26.1M USD -11.4%
Intangible Assets, Net (Excluding Goodwill) 540M USD -15.8%
Goodwill 117M USD 0%
Other Assets, Noncurrent 33.6M USD -13.3%
Assets 1.34B USD +4.48%
Accounts Payable, Current 6.39M USD +88.6%
Employee-related Liabilities, Current 20.3M USD +6.62%
Accrued Liabilities, Current 75.8M USD -3.4%
Liabilities, Current 292M USD +1.38%
Deferred Income Tax Liabilities, Net 7.36M USD -79.1%
Operating Lease, Liability, Noncurrent 28.9M USD -14.5%
Other Liabilities, Noncurrent 7.35M USD -14.5%
Liabilities 336M USD -10%
Accumulated Other Comprehensive Income (Loss), Net of Tax 78K USD
Retained Earnings (Accumulated Deficit) 541M USD +12.4%
Stockholders' Equity Attributable to Parent 1.01B USD +10.4%
Liabilities and Equity 1.34B USD +4.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 38.4M USD -21.8%
Net Cash Provided by (Used in) Financing Activities 1.57M USD -98%
Net Cash Provided by (Used in) Investing Activities -51.6M USD -122%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 55.2M shares +1.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31.7M USD -66.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 59.6M USD -15.5%
Deferred Tax Assets, Gross 194M USD -9.47%
Operating Lease, Liability 38.2M USD -9.85%
Payments to Acquire Property, Plant, and Equipment 248K USD -10.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 38.9M USD
Lessee, Operating Lease, Liability, to be Paid 50.8M USD -11.4%
Property, Plant and Equipment, Gross 29.1M USD +1.79%
Operating Lease, Liability, Current 9.23M USD +8.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.65M USD -1.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.26M USD +5.28%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -5.48M USD -1160%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.97M USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.67M USD -18.6%
Deferred Tax Assets, Operating Loss Carryforwards 113M USD -10.9%
Unrecognized Tax Benefits 4.32M USD -29.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.53M USD -15.1%
Operating Lease, Payments 4M USD +15.8%
Additional Paid in Capital 466M USD +7.86%
Amortization of Intangible Assets 19.5M USD -8.26%
Depreciation, Depletion and Amortization 20.7M USD +0.72%
Deferred Tax Assets, Net of Valuation Allowance 135M USD -6.52%
Share-based Payment Arrangement, Expense 7.67M USD -3.11%
Interest Expense 0 USD -100%